Having worked in the British, French and Swiss financial press, Romain is able to report on local and international issues, as comfortable in French as in the language of Shakespeare, Romain Fournier leads the editorial team at Marketscreener. Fine connoisseur of the English-speaking markets, Romain delivers an editorial every day on US and UK markets.
Analyst recommendations: Johnson & Johnson, NatWest, Home Depot, Kraft Heinz, Vodafone...
Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.
Anthem: Morgan Stanley downgrades to equal-weight from overweight. PT jumps 16% to $533.
Brixmor Property: J.P. Morgan upgrades to overweight from neutral. PT jumps 27% to $25.
Celanese Corporation: Alembic Global Advisors lowers price target to $165 from $200, maintains overweight rating.
Ceres Power: Goldman Sachs upgrades from sell to buy targeting GBp 700.
Cigna: Morgan Stanley upgrades to overweight from equal-weight. PT up 17% to $296.
Corteva: BofA Securities raises price target to $57 from $51, maintains underperform rating.
CRISPR Therapeutics: Piper Sandler adjusts price target to $121 from $115, reiterates overweight rating.
Equity Residential: RBC Capital Markets upgrades to outperform from sector perform. PT rises 11% to $79.
Johnson & Johnson: Daiwa Securities initiated coverage with a recommendation of outperform. PT up 4% to $180.
Kroger: MKM Partners raises price target to $55 from $48, maintains neutral rating.
Lennar Corporation: Barclays adjusts price target to $85 from $93, keeps equalweight rating.
PNM Resources: Mizuho Securities upgrades to buy from neutral. PT up 16% to $52.
Medical properties: J.P. Morgan downgrades to neutral from overweight. PT rises 23% to $18.
NatWest: Jefferies upgrades from hold to buy targeting GBp 359.